KP?.do you think you know more than the ANP board...THIS FROM THE TECH UPDATE...
"Relevance to ANP: Ionis now have 2 antisense drugs registered with the FDA (Kynamro®, and SPINRAZA) and 12 other drugs in their clinical pipeline (including all the drugs referred to above in clinical development) of the same basic chemistry as ATL1102 and ATL1103. Most of these drugs have been out licensed, including to Big Pharma companies including Bayer, Roche, GSK, and Biogen. Such progress provides important clinical, regulatory, and commercial validation for ANP’s product technology."
KP..you Sold out..yet you try to frighten investors..with non factual nonsense...
Ionis has 3 gen 2 drugs which are about to be commercialised....ANP chemistry is the same ..
ANP Price at posting:
3.2¢ Sentiment: Buy Disclosure: Held
